KUALA LUMPUR, Feb 26 (Bernama) -- Public-listed healthcare company, Malaysian Genomics Resource Centre Berhad (MGRC), and its subsidiary, pathology services company Clinipath (Malaysia) Sdn Bhd (Clinipath) today announced the availability of Dtect Derma, a comprehensive genetic screening test that examines key genes associated with aesthetics and skin health.

Dtect Derma offers an extensive profile of traits related to skin youthfulness and premature ageing. Skin youthfulness is dependent upon many biological factors including nutrient metabolism, cellular ageing, collagen homeostasis (including collagen production, integrity and turnover), hydration, and elasticity. Premature ageing of the skin can be caused by lower collagen production, lower hydration, loss of elasticity, thinning of the skin, and age-related discolouration among many other factors.

Although the environment plays an important role in skin health, genetics are also involved in modulating the body’s response to harmful environmental factors such as protection against UV radiation and photoaging. The results from advanced genetic screening tests such as Dtect Derma can identify predispositions to various causes of premature ageing which may be used by doctors and patients to personalise skin care regimes to prolong health and wellness.

MGRC and Clinipath continue to work together to make comprehensive pathology services, and the latest in genetic testing available to doctors with a view to improving the lives of patients in Malaysia and the region.

About Malaysian Genomics Resource Centre Berhad

MGRC was a pioneer in genome sequencing, bioinformatics analysis and genetic screening services. Since 2004, MGRC had developed extensive pipelines in the sequencing and analysis of human, animal, plant and microbial genomes for clients worldwide. Today, MGRC is focused on merging the latest in genetic testing with pathology to enable doctors to provide personalised healthcare for their patients.

About Clinipath (Malaysia) Sdn Bhd

Clinipath is one of Malaysia’s largest independent pathology service providers with a nationwide network of 18 branches. It offers a complete range of fast, accurate and reliable pathology testing services. It has been ISO 15189 accredited since 2010. Clinipath is a wholly-owned subsidiary of public-listed MGRC.

Source: Clinipath Malaysia Sdn Bhd

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Shawn Keng
Tel: +6014-9685808
Email: enquiries@mgrc.com.my
 
--BERNAMA